from$105
GLP-1 & Metabolic · SKU C-10
Cagrilintide 10 mg
Long-acting amylin analogue studied alongside GLP-1 agonists in metabolic research.
$ 170 per 10 mg vial · free shipping over $300
In stock · ships same day on orders before 2pm ET
Purity (HPLC-UV)≥99.0% on lot CAG-2609-X
IdentityConfirmed by LC-MS
FormLyophilized powder, sealed vial
Endotoxin< 0.5 EU/mg (LAL)
Storage-20°C sealed · 2-8°C reconstituted
CertificateView COA for CAG-2609-X →
CAS number1415456-99-3
Molecular formulaC194H312N54O59S2
Molecular weight4409 g/mol
PubChemCID 171397054
Volume pricing, applied automatically in the cart
| Quantity | Per unit | You save |
|---|---|---|
| 3 to 4 units | $158.10 | 7% |
| 5 to 9 units | $151.30 | 11% |
| 10+ units | $142.80 | 16% |
Verify lot CAG-2609-X in the COA library · This month's lot report
Ships same day on orders before 2pm ET. For laboratory research use only. Not for human or animal consumption.
Frequently bought together
Supplies researchers add to this order
Reconstitution solution30 mL · $25
Reconstitution kitKit · $49.99
What is Cagrilintide?
Cagrilintide is a long-acting synthetic analogue of amylin, the 37-amino-acid hormone co-secreted with insulin by pancreatic beta cells. It is acylated to extend its half-life and is studied alongside GLP-1 receptor agonists because amylin and incretin signalling act on appetite and gastric emptying through separate receptor systems. Pepstral supplies it as a lyophilized powder for in-vitro laboratory research only.
What is Cagrilintide studied for?
- Amylin and calcitonin receptor binding assays
- Combination studies with GLP-1 receptor agonists
- Gastric emptying models
- Energy-balance signalling research
All applications above are in-vitro or preclinical research contexts. Cagrilintide is sold for laboratory research only and is not for human or animal use.
What does the certificate for lot CAG-2609-X show?
Every lot of Cagrilintide is tested by an independent US laboratory before it is listed. The report for lot CAG-2609-X is in the COA library and the lot number printed on the vial matches it. The current results:
| Test | Method | Lot CAG-2609-X result |
|---|---|---|
| Identity | LC-MS | Matches the calculated mass for the sequence |
| Purity | HPLC-UV, 220 nm | 99.0% |
| Net peptide content | Amino acid analysis | Stated per vial on the certificate |
| Endotoxin | LAL, chromogenic | < 0.5 EU/mg |
| Sterility | USP <71> | Pass |
How is Cagrilintide handled and stored?
Sealed vials are stored at -20°C away from light and keep for 24 months. To reconstitute, add bacteriostatic water slowly down the inside wall of the vial and swirl until clear; never shake. Once in solution, keep at 2 to 8°C and use within the 28-day window on the certificate. The reconstitution guide covers volumes and syringe units and the concentration table gives the numbers for this vial.
Frequently asked questions
Why is cagrilintide studied with GLP-1 agonists?
The two act through different receptor families, so a combination lets researchers separate amylin-mediated effects from incretin-mediated ones in the same model.
Is cagrilintide the same as pramlintide?
No. Both are amylin analogues, but cagrilintide is acylated for a longer half-life and has a different substitution pattern.
Is Cagrilintide for human use?
No. Every product on this site is sold for in-vitro laboratory research only and is not for human or animal consumption, diagnostic or therapeutic use.
Related reading
Related
More in GLP-1 & Metabolic
from$100
from$60
from$60
